The third booster vaccination dose against COVID-19: Indications for circulating SARS-CoV-2 variants

Farid Rahimi; Amin Talebi Bezmin Abadi

doi:10.2217/fvl-2021-0240

The third booster vaccination dose against COVID-19: Indications for circulating SARS-CoV-2 variants

Farid Rahimi
, Amin Talebi Bezmin Abadi^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)

Abstract

Documenting the vaccine type, its booster dosing, target populations, optimal dosing intervals and the vaccination timeline is crucial for determining the vaccine effectiveness against the existing or new SARS-CoV-2 variants. Any change in the future statistics of COVID-19 may help us better understand the virus and its potential seasonally emerging variants akin to the seasonal flu or measles.

Original language	English
Pages (from-to)	781-784
Number of pages	4
Journal	Future Virology
Volume	16
Issue number	12
DOIs	https://doi.org/10.2217/fvl-2021-0240
Publication status	Published - Dec 2021

Access to Document

10.2217/fvl-2021-0240

Cite this

@article{79cc04187e9d4b539a973561b7165943,

title = "The third booster vaccination dose against COVID-19: Indications for circulating SARS-CoV-2 variants",

abstract = "Documenting the vaccine type, its booster dosing, target populations, optimal dosing intervals and the vaccination timeline is crucial for determining the vaccine effectiveness against the existing or new SARS-CoV-2 variants. Any change in the future statistics of COVID-19 may help us better understand the virus and its potential seasonally emerging variants akin to the seasonal flu or measles.",

keywords = "Booster immunization, COVID-19 vaccines, Pandemic, SARS-CoV-2 variants",

author = "Farid Rahimi and Abadi, \{Amin Talebi Bezmin\}",

year = "2021",

month = dec,

doi = "10.2217/fvl-2021-0240",

language = "English",

volume = "16",

pages = "781--784",

journal = "Future Virology",

issn = "1746-0794",

publisher = "Taylor and Francis Ltd.",

number = "12",

}

TY - JOUR

T1 - The third booster vaccination dose against COVID-19

T2 - Indications for circulating SARS-CoV-2 variants

AU - Rahimi, Farid

AU - Abadi, Amin Talebi Bezmin

PY - 2021/12

Y1 - 2021/12

N2 - Documenting the vaccine type, its booster dosing, target populations, optimal dosing intervals and the vaccination timeline is crucial for determining the vaccine effectiveness against the existing or new SARS-CoV-2 variants. Any change in the future statistics of COVID-19 may help us better understand the virus and its potential seasonally emerging variants akin to the seasonal flu or measles.

AB - Documenting the vaccine type, its booster dosing, target populations, optimal dosing intervals and the vaccination timeline is crucial for determining the vaccine effectiveness against the existing or new SARS-CoV-2 variants. Any change in the future statistics of COVID-19 may help us better understand the virus and its potential seasonally emerging variants akin to the seasonal flu or measles.

KW - Booster immunization

KW - COVID-19 vaccines

KW - Pandemic

KW - SARS-CoV-2 variants

UR - https://www.scopus.com/pages/publications/85120379342

U2 - 10.2217/fvl-2021-0240

DO - 10.2217/fvl-2021-0240

M3 - Review article

SN - 1746-0794

VL - 16

SP - 781

EP - 784

JO - Future Virology

JF - Future Virology

IS - 12

ER -

The third booster vaccination dose against COVID-19: Indications for circulating SARS-CoV-2 variants

Abstract

Access to Document

Other files and links

Fingerprint

Cite this